The Oncologist: 2023, vol: , issue:
- 1)- Daniel E McLoughlin, Nicholas Chevalier, Edwin Choy, Gregory M Cote, Xin Gao, Dejan Juric, Kerry L Reynolds. A Rare Presentation of Aggressive Renal Cell Carcinoma and the Utility of Early Molecular Testing in Rapidly Progressing Malignancies: A Case Report. The oncologist. 2023, 28 (12): 1094-1099
Cited : 1Read More - 2)- Yaxin Liu, Guohong Song, Lijun Di, Hanfang Jiang, Ran Ran, Ruyan Zhang, Yan Zhang, Huiping Li. Three-Week Versus 4-Week Schedule of nab-Paclitaxel in Patients With Metastatic Breast Cancer: A Randomized Phase II Study. The oncologist. 2023, 28 (12): 1102-e1302Cited : 0Read More
- 3)- Alex G Thomas, Alyx B Porter. Promoting Inclusive Cancer Care: Beyond Medical Interpreters. The oncologist. 2023, 28 (12): e1131-e1133Cited : 0Read More
- 4)- Yuanming Xu, Natalie Wen, Robert I Haddad, Stephen T Sonis, Alessandro Villa. Comparisons of Nonoral Immune-Related Adverse Events Among Patients With Cancer With Different Oral Toxicity Profiles. The oncologist. 2023, : Cited : 0Read More
- 5)- Eriko Tokunaga, Yasuo Miyoshi, Koji Dozono, Tsutomu Kawaguchi, Masakazu Toi. Association of Neutrophil-to-Lymphocyte Ratio and Absolute Lymphocyte Count With Clinical Outcomes in Advanced Breast Cancer in the MONARCH 2 Trial. The oncologist. 2023, : Cited : 2Read More
- 6)- Adriana M Kahn, Curtis J Perry, Katrina Etts, Harriet Kluger, Mario Sznol. Clinical Predictors of Survival in Patients With BRAFV600-Mutated Metastatic Melanoma Treated With Combined BRAF and MEK Inhibitors After Immune Checkpoint Inhibitors. The oncologist. 2023, : Cited : 0Read More
- 7)- Ronald Chow, Hannah Drkulec, James H B Im, Jane Tsai, Abdulwadud Nafees, Swetlana Kumar, Tristan Hou, Rouhi Fazelzad, Natasha B Leighl, Monika Krzyzanowska, Philip Wong, Srinivas Raman. The Use of Wearable Devices in Oncology Patients: A Systematic Review. The oncologist. 2023, : Cited : 5Read More
- 8)- Sara Socorro Faria, Diana Giannarelli, Vladmir Claudio Cordeiro de Lima, Sumadi Luckman Anwar, Chiara Casadei, Ugo De Giorgi, Gabriele Madonna, Paolo Antonio Ascierto, Rossana Veronica Mendoza López, Roger Chammas, Mariaelena Capone. Development of a Prognostic Model for Early Breast Cancer Integrating Neutrophil to Lymphocyte Ratio and Clinical-Pathological Characteristics. The oncologist. 2023, : Cited : 0Read More
- 9)- Yosuke Kito, Hisato Kawakami, Seiichiro Mitani, Shinichi Nishina, Toshihiko Matsumoto, Takao Tsuzuki, Yudai Shinohara, Hozumi Shimokawa, Ryosuke Kumanishi, Takashi Ohta, Hiroo Katsuya, Takeshi Kawakami, Tomohiro Nishina, Hiroko Hasegawa, Kohei Akiyoshi, Yasutaka Chiba, Kentaro Yamazaki, Shuichi Hironaka, Kei Muro. Trifluridine/Tipiracil Plus Bevacizumab for Vulnerable Patients With Pretreated Metastatic Colorectal Cancer: A Retrospective Study (WJOG14520G). The oncologist. 2023, : Cited : 1Read More
- 10)- Rana R McKay, Katharina Leucht, Wanling Xie, Opeyemi Jegede, David A Braun, Michael B Atkins, Marc-Oliver Grimm, Toni K Choueiri. A Pooled Analysis of 3 Phase II Trials of Salvage Nivolumab/Ipilimumab After Nivolumab in Renal Cell Carcinoma. The oncologist. 2023, : Cited : 0Read More
- 11)- Chan Shen, J Douglas Thornton, Ning Li, Eric Schaefer, Shouhao Zhou, Sarah Kawasaki, Colette Pameijer, Douglas Leslie. Opioid and Non-Opioid Pharmacotherapy Use for Pain Management Among Privately Insured Pediatric Patients With Cancer in the United States. The oncologist. 2023, : Cited : 0Read More
- 12)- Lorenzo Gerratana, Masha Kocherginsky, Andrew A Davis, Paolo D'Amico, Carolina Reduzzi, Fabio Puglisi, Massimo Cristofanilli. Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast Cancer: A Retrospective Analysis of the MONARCH 2 Trial. The oncologist. 2023, : Cited : 0Read More
- 13)- Richard A Newcomb, P Connor Johnson, Daniel Yang, Katherine Holmbeck, Joanna Choe, Anisa Nabily, Porsha Lark, Tejaswini Dhawale, Hermioni L Amonoo, Areej El-Jawahri. Coping and Perception of Prognosis in Patients With Indolent Non-Hodgkin's Lymphoma. The oncologist. 2023, : Cited : 1Read More
- 14)- Fidel Rubagumya, Brooke Wilson, Achille Manirakiza, Emmanuel Mutabazi, Diane A Ndoli, Emmanuel Rudakemwa, Mary D Chamberlin, Wilma M Hopman, Christopher M Booth. Financial Toxicity: Unveiling the Burden of Cancer Care on Patients in Rwanda. The oncologist. 2023, : Cited : 2Read More
- 15)- Christina Vivelo, Karlyne M Reilly, Brigitte C Widemann, Mary Frances Wedekind, Corrie Painter, Allison F O'Neill, Sabine Mueller, Olivier Elemento, Andrea M Gross, Abby B Sandler. The Landscape of US and Global Rare Tumor Research Programs: A Systematic Review. The oncologist. 2023, : Cited : 0Read More
- 16)- Jiun-I Lai, Ting-Hao Kuo, Kuan-Jung Huang, Laura Min Xuan Chai, Mei-Hsuan Lee, Chun-Yu Liu, Yi-Fang Tsai, Chi-Cheng Huang, Ling-Ming Tseng, Cheng-Chih Hsu, Ta-Chung Chao. Clinical and Genotypic Insights Into Higher Prevalence of Palbociclib Associated Neutropenia in Asian Patients. The oncologist. 2023, : Cited : 3Read More
- 17)- Feng Lin, Winghan Jacqueline Kwong, Irene Pan, Xin Ye, Dong Dai, William Tap. Real-World Patient Experience of Pexidartinib for Tenosynovial Giant-Cell Tumor. The oncologist. 2023, : Cited : 0Read More
- 18)- Xiaohong Guo, Li Wang, Narasimha M Beeraka, Chunying Liu, Xiang Zhao, Runze Zhou, Huiming Yu, Ruitai Fan, Junqi Liu. Incidence Trends, Clinicopathologic Characteristics, and Overall Survival Prediction in Retinoblastoma Children: SEER Prognostic Nomogram Analysis. The oncologist. 2023, : Cited : 0Read More
- 19)- Jianwei Liu, Xiaodong Zhu, Yangxun Pan, Jianhong Zhong, Renan Jin, Xin Zheng, Wei Zhang, Kuan Hu, Jian Ma, Xiaoyi Shi, Hongzhi Liu, Xiaobo Yang, Da Xu, Chi Ma, Jiangming Chen, Dongxu Wang, Xiaojun Wang, Zhongchao Li, Lei Zhao, Leida Zhang, Tao Li, Fubao Liu, Guang Tan, Baocai Xing, Haitao Zhao, Yongyi Zeng, Shuijun Zhang, Lei Zhang, Ledu Zhou, Tianqiang Song, Wei Yang, Xiao Liang, Bangde Xiang, Li Xu, Huichuan Sun, Kui Wang. Prognoses of Patients Treated With Surgical Therapy Versus Continuation of Local-Plus-Systemic Therapy Following Successful Down-Staging of Intermediate-Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study. The oncologist. 2023, : Cited : 4Read More
- 20)- Guofeng Ma, Huiqing Jia, Guofang Zhang, Ye Liang, Xianning Dong, Guangming Fu, Xinsheng Wang, Haitao Niu. Presence, Subtypes, and Prognostic Significance of Tertiary Lymphoid Structures in Urothelial Carcinoma of the Bladder. The oncologist. 2023, : Cited : 4Read More
- 21)- Carlos Eduardo Paiva, Bianca Sakamoto Ribeiro Paiva. Challenging Rationality: Examining the Belief in Cure Among Patients With Advanced Incurable Cancers. The oncologist. 2023, : Cited : 0Read More
- 22)- Shilpa Gupta, Halley Costantino, Chiemeka Ike, Shaloo Gupta, Abhijeet Bhanegaonkar, Cathy Su, Sheena Thakkar, deMauri S Mackie, Geeta Devgan, Howard M Katzenstein, Frank X Liu. Evaluating Oncologists' Practice Patterns and Decision-Making in Locally Advanced or Metastatic Urothelial Carcinoma: The US Physician PARADIGM Study. The oncologist. 2023, : Cited : 0Read More
- 23)- Valisha Shah, William Lotter. Toward More Accurate Preoperative Diagnosis of Vein Wall Invasion in Renal Cell Carcinoma Using Computer Vision. The oncologist. 2023, : Cited : 0Read More
- 24)- . Correction to: AZD8186 in Combination With Paclitaxel in Patients With Advanced Gastric Cancer: Results From a Phase Ib/II Study (KCSG ST18-20). The oncologist. 2023, : Cited : 0Read More
- 25)- Neal D Shore, Maha Hussain, Fred Saad, Karim Fizazi, Cora N Sternberg, David Crawford, Bertrand Tombal, Luke Nordquist, Michael Cookson, Frank Verholen, Jay Jhaveri, Shankar Srinivasan, Matthew R Smith. Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS Trial. The oncologist. 2023, : Cited : 1Read More
- 26)- . Correction to: Comparisons of Nonoral Immune-Related Adverse Events Among Patients With Cancer With Different Oral Toxicity Profiles. The oncologist. 2023, : Cited : 0Read More
- 27)- Wali Badar, Qian Yu, Mikin Patel, Osman Ahmed. Transarterial Radioembolization for Management of Hepatocellular Carcinoma. The oncologist. 2023, : Cited : 3Read More
- 28)- Salvatore Alfieri, Rebecca Romanò, Sara Marceglia, Vincenzo De Giorgi, Ketty Peris, Pietro Sollena, Alfredo Piccerillo, Ruggero Moro, Giulio Gualdi, Paolo Antonio Ascierto, Marco Palla, Miriam Paone, Laura Eibenschutz, Francesco Spagnolo, Paola Queirolo, Daria Maria Filippini, Stefano Cavalieri, Carlo Resteghini, Cristiana Bergamini, Antonello Manocchio, Lisa Licitra, Paolo Bossi. Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go? The oncologist. 2023, : Cited : 2Read More
- 29)- Ilse A C Spiekman, Birgit S Geurts, Laurien J Zeverijn, Gijs F de Wit, Vincent van der Noort, Paul Roepman, Wendy W J de Leng, Anne M L Jansen, Benno Kusters, Laurens V Beerepoot, Filip Y F L de Vos, Derk-Jan A de Groot, Jan Willem B de Groot, Ann Hoeben, Jan Buter, Hans A J Gelderblom, Emile E Voest, Henk M W Verheul. Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol. The oncologist. 2023, : Cited : 0Read More
- 30)- Michael LaPelusa, Christopher Cann, Kristen K Ciombor, Cathy Eng. Mutational Signature Changes in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal. The oncologist. 2023, : Cited : 0Read More
- 31)- . Correction to: The Evolving Landscape of Immune Checkpoint Inhibitors and Antibody Drug Conjugates in the Treatment of Early-Stage Breast Cancer. The oncologist. 2023, : Cited : 0Read More
- 32)- Joana Albuquerque, Diana Neto da Silva, Teresa Padrão, Luísa Leal-Costa, Rita Bizarro, Jorge Correia, Carlota Baptista, Madalena Machete, Gil Prazeres, Inês Margarido, Gonçalo Fernandes, Pedro Simões, Teresa Timóteo, Fábio Lopes, João Godinho, João Moreira-Pinto, Tânia Rodrigues, Ana Faria, Catarina Pulido, Luís Cirnes, José A Teixeira, José L Passos Coelho. Loss of RAS Mutations in Liquid Biopsies of Patients With Multi-Treated Metastatic Colorectal Cancer. The oncologist. 2023, : Cited : 0Read More
- 33)- Jason A Mouabbi, Wei Qaio, Yu Shen, Akshara Singareeka Raghavendra, Debasish Tripathy, Rachel M Layman. Efficacy of Single-Agent Chemotherapy in Endocrine Therapy-Refractory Metastatic Invasive Lobular Carcinoma. The oncologist. 2023, : Cited : 0Read More
- 34)- Sarah Menig, Olga Militano, Andrew Ostrenga, M Brooke Bernhardt, Brittany Lee, Yoram Unguru. Methotrexate Scarcity Among Children's Oncology Group Institutions: Results of a Multinational Survey. The oncologist. 2023, : Cited : 2Read More
- 35)- Marta Maccari, Chooyoung Baek, Mario Caccese, Susanna Mandruzzato, Alba Fiorentino, Valeria Internò, Alberto Bosio, Giulia Cerretti, Marta Padovan, Ahmed Idbaih, Giuseppe Lombardi. Present and Future of Immunotherapy in Patients With Glioblastoma: Limitations and Opportunities. The oncologist. 2023, : Cited : 3Read More
- 36)- Toni K Choueiri, Sumanta K Pal, Bryan Lewis, Susan Poteat, Kevin Pels, Hans Hammers. The 5th Kidney Cancer Research Summit: Research Accelerating Cures for Renal Cell Carcinoma in 2023. The oncologist. 2023, : Cited : 0Read More
- 37)- Marco Maria Germani, Chiara Boccaccio, Antonio Matrone, Eleonora Molinaro, Greta Alì, Mirella Giordano, Rossella Elisei, Gabriella Fontanini, Chiara Cremolini. A Misleading Case of NTRK-Rearranged Papillary Thyroid Carcinoma. The oncologist. 2023, : Cited : 1Read More
- 38)- Andrew W Hahn, Devaki Shilpa Surasi, Paul V Viscuse, Tharakeswara K Bathala, Andrew J Wiele, Matthew T Campbell, Amado J Zurita, Amishi Y Shah, Eric Jonasch, Jianjun Gao, Sangeeta Goswami, Omar Alhalabi, Priya Rao, Kanishka Sircar, Nizar M Tannir, Pavlos Msaouel. Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy. The oncologist. 2023, : Cited : 2Read More
- 39)- Athanasios Pogkas, Peter Reichardt, Per-Ulf Tunn, Maya Niethard, Mathias Werner, Saeed Ghani. Localized Myxofibrosarcoma: A Retrospective Analysis of Primary Therapy and Prognostic Factors in 134 Patients in a Single Institution. The oncologist. 2023, : Cited : 3Read More
- 40)- Whitney V Johnson, Quan H Phung, Vishal R Patel, Alexander K Tsai, Nivedita Arora, Mark A Klein, Anders D Westanmo, Anne H Blaes, Arjun Gupta. Trajectory of Healthcare Contact Days for Veterans With Advanced Gastrointestinal Malignancy. The oncologist. 2023, : Cited : 4Read More
- 41)- Edurne Arriola, Jana Jaal, Anne Edvardsen, Maria Silvoniemi, António Araújo, Anders Vikström, Eleni Zairi, Mari Carmen Rodriguez-Mues, Marco Roccato, Sophie Schneider, Johannes Ammann. Feasibility and User Experience of Digital Patient Monitoring for Real-World Patients With Lung or Breast Cancer. The oncologist. 2023, : Cited : 1Read More
- 42)- Matthew Anaka, David Chan, Sharon Pattison, Alia Thawer, Bryan Franco, Lesley Moody, Christopher Jackson, Eva Segelov, Simron Singh. Patient Priorities Concerning Treatment Decisions for Advanced Neuroendocrine Tumors Identified by Discrete Choice Experiments. The oncologist. 2023, : Cited : 0Read More
- 43)- Rongzhi Wang, Rhiannon D Reed, Griffin Price, Peter Abraham, Marshall Lewis, Jessica Liu McMullin, Paul MacLennan, Cozette Killian, Jayme E Locke, Song Ong, Vineeta Kumar, Andrea Gillis, Brenessa Lindeman, Herbert Chen, Jessica Fazendin. Treatment of Hypercalcemic Hyperparathyroidism After Kidney Transplantation Is Associated With Improved Allograft Survival. The oncologist. 2023, : Cited : 1Read More
- 44)- . Correction to: Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung Cancer. The oncologist. 2023, : Cited : 0Read More
- 45)- Andrea Botticelli, Roberta Caputo, Simone Scagnoli, Simona Pisegna, Michelino De Laurentiis, Giuseppe Curigliano, Matteo Lambertini, Francesco Pantano, Antonella Palazzo, Ida Paris, Claudio Vernieri, Beatrice Tedesco, Marianna Giampaglia, Michela Palleschi, Zelmira Ballatore, Daniele Alesini, Giuliana D'Auria, Agnese Fabbri, Luigi Rossi, Annarita Verrazzo, Roberta Scafetta, Daniele Marinelli, Caterina Sposetti, Vittoria Barberi, Lidia Strigari, Paolo Marchetti, Daniele Santini, Alessandra Fabi. Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study. The oncologist. 2023, : Cited : 3Read More
- 46)- Meenakkshy Manoharan, Noah S Kalman, Guilherme Rabinowits. Head and Neck Squamous Cell Carcinoma of Unknown Primary: A Diagnostic Work-Up. The oncologist. 2023, : Cited : 4Read More
- 47)- Gerti Dajti, Margherita Serra, Giovanni Cisternino, Claudio Ceccarelli, Alice Pellegrini, Marica Melina, Antonio De Leo, Donatella Santini, Mario Taffurelli, Simone Zanotti. Prognostic Role of p53 Immunohistochemical Status in invasive Breast Cancer. A Retrospective Review of 1387 Cases With Luminal-Like/Her2 Negative Breast Tumors. The oncologist. 2023, : Cited : 1Read More
- 48)- Daniël J van der Meer, Susan Zevenbergen, Carla Vlooswijk, Rhodé M Bijlsma, Suzanne E J Kaal, Jan Martijn Kerst, Jacqueline M Tromp, Monique E M M Bos, Tom van der Hulle, Roy I Lalisang, Janine Nuver, Mathilde C M Kouwenhoven, Winette T A van der Graaf, Olga Husson. Patient-Reported Outcomes of Accelerated Aging: A Novel Approach to Investigate Second Cancer Risk in Adolescent and Young Adult (18-39 Years) Cancer Survivors. The oncologist. 2023, : Cited : 0Read More
- 49)- Abdul Rafae, Frits van Rhee, Samer Al Hadidi. Perspectives on the Treatment of Multiple Myeloma. The oncologist. 2023, : Cited : 5Read More
- 50)- Charlotte Sikking, Kelly L Niggebrugge-Mentink, A S Elise van der Sman, Roefke H P Smit, Esther W Bouman-Wammes, Marieke M Beex-Oosterhuis, Charlotte van Kesteren. Hydration Methods for Cisplatin Containing Chemotherapy: A Systematic Review. The oncologist. 2023, : Cited : 2Read More
